Hanyang University

Five Korean research teams selected for the 'Global Center Program,' joining international joint research on 'Biodiversity Utilization' and 'Biofoundries' with six countries for five years.

Jonathan Lovell, UB professor, and NYS researchers are developing an immunotherapy vaccine targeting multiple epitopes of amyloid-beta and tau proteins to treat Alzheimer’s. The vaccine, tested on mice, showed reduced Alzheimer’s-related brain damage and improved cognitive performance without side effects. The team aims to secure FDA approval for human trials, potentially within the next few years.